HEMATOPOIETIC STEM CELL TRANSPLANT IN INFANTILE OSTEOPETROSIS: NAVIGATING THROUGH THE MAZE

EHA Library, Hashim Khan, 4161165

THE FIRST ALLOGENEIC STEM CELL TRANSPLANT IN KENYA: A CASE REPORT

EHA Library, Rohini Radia, 4161167

S100A8/A9 SIGNALING CAUSES MITOCHONDRIAL DYSFUNCTION AND MEGAKARYOCYTE APOPTOSIS IN ACUTE MYELOID LEUKEMIA

EHA Library, Mengyu Xiao, 4161168

PHARMACOLOGICAL ACTIVATION OF CAMP PATHWAY PROTECTS HUMAN HEMATOPOIETIC STEM CELLS FROM CAR-T INDUCED HEMATO-TOXICITY

EHA Library, Siva Sai Naga Anurag Muddineni, 4161172

DEVELOPMENT OF A TRACTABLE EX VIVO MODEL OF HAEMATOPOIESIS

EHA Library, Elizabeth Brown, 4161173

ELEVATED UBE2G1 EXPRESSION IN HSCS LEADS TO PREMATURE AGING OF THE HAEMATOPOIETIC SYSTEM

EHA Library, Julian Niemann, 4161174

SPECIFIC GENETIC ALTERATIONS IN BCMA POSITIVE CELLS UNCOVER MYELOPROLIFERATIVE PHENOTYPES AND AN IMMUNOSUPPRESSIVE NICHE IN MURINE HEMATOPOIETIC MODELS

EHA Library, Álvaro Otero-Sobrino, 4161177

RAPID RESPONSE OF NEUTROPHILS DETERMINED BY THE SHORTEST LINEAGE COMMITMENT TRAJECTORY AND MINIMAL SIGNALING CHANGES

EHA Library, Yongjian Yue, 4161178

CH-MUTATED MACROPHAGES CONTRIBUTE TO A PERMISSIVE BONE MARROW NICHE FOR MALIGNANT TRANSFORMATION.

EHA Library, Sarah Mackie, 4161179

THERAPY RELATED CLONAL HEMATOPOESIS IS ASSOCIATED WITH INCREASED EPIGENETIC AGE ACCELERATION, INCREASED PACE OF AGING AND SHORTED ESTIMATED TELOMERE LENGTHS

EHA Library, Marissa Li, 4161184

AUTOIMMUNE CYTOPENIAS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES

EHA Library, Irina Krobinets, 4161185

PARP INHIBITORS IMPAIR ERYTHROPOIESIS THROUGH P53 ACTIVATION

EHA Library, Charlotte Chambrion, 4161187

MOSAIC CHROMOSOMAL ABERRATIONS AND ASSOCIATION TO HEMATOLOGICAL CANCER

EHA Library, Pei Meng, 4161189

SINGLE-CELL SEQUENCING REVEALED THE INFLAMMATORY SEGREGATION PHENOMENON AND THE KEY ROLE OF CLASSICAL DENDRITIC CELLS IN PEDIATRIC UNICENTRIC CASTLEMAN DISEASE

EHA Library, Shiwen Hu, 4161190

LEUKEMIA EXOSOMES INDUCE IMMUNE SUPPRESSION IN DENDRITIC CELLS THROUGH ANTIGEN PRESENTATION AND IMMUNE METABOLISM REGULATION

EHA Library, Jinglong Lv, 4161192

ENGINEERING ROR1-SPECIFIC CAR T CELLS AGAINST LOW ANTIGEN DENSITY TUMORS

EHA Library, Federico Mario Aletti, 4161199

BEYOND EXPANSION: CIRCULATING TUMOR DNA AS A PROGNOSTIC BIOMARKER IN CAR T-CELL THERAPY FOR HIGH GRADE B-CELL LYMPHOMAS

EHA Library, Giada Zanirato, 4161200

TARGETING CATHEPSIN G PEPTIDES ON TWO DIFFERENT HLA MOLECULES WITH AN INDIVIDUAL T CELL RECEPTOR: A PROMISING APPROACH FOR ACUTE MYELOID LEUKEMIA IMMUNOTHERAPY

EHA Library, Eliana Ruggiero, 4161202

IMPROVING CAR-T CELL THERAPY FOR PDAC BY GENERATION OF VHH-BASED BINDERS

EHA Library, Alexander Seitz, 4161205

ATRA INCREASES INKT CELL-MEDIATED TARGETING IN HEMATOLOGICAL MALIGNANCIES BY INDUCING CD1D EXPRESSION

EHA Library, Eliska Jandova, 4161208

EVALUATION OF MESENCHYMAL STEM CELL INTERMEDIATES IN 2015-2023

EHA Library, Hana Gmucova, 4161211

GREATWALL INHIBITOR-POTENTIAL NOVEL TREATMENT IN HEMATOLOGICAL MALIGNANCIES?

EHA Library, Elaina Pasangha, 4161212

INKT-BASED CELLULAR PRODUCT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE

EHA Library, Monika Holubova, 4161213

ARMORED GPRC5D/BCMA BISPECIFIC CAR-T OVERCOMES THE TUMOR MICROENVIRONMENT TO ENHANCE ANTITUMOR EFFICACY

EHA Library, XIAOWEN HE, 4161217

NCG-X: A NOVEL MOUSE MODEL FOR PRECLINICAL STUDIES EVALUATING HUMANIZED ERYTHROID RECONSTITUTION

EHA Library, Hongyan Sun, 4161219

ANTI-BCMA/GPRC5D BISPECIFIC CAR T CELLS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE

EHA Library, Dian Zhou, 4161221

REDUCED OUTCOMES WITH PROTON PUMP INHIBITOR USE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH CD19-DIRECTED CAR T-CELL THERAPY: A POPULATION-BASED ANALYSIS FROM THE DUTCH CAR T-CENTERS

EHA Library, Jaap Van Doesum, 4161222

MANAGEMENT OF IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME FOLLOWING CAR-T CELL THERAPY IN CLINICAL PRACTICE: A MULTICENTRIC, RETROSPECTIVE, REAL-WORLD ANALYSIS OF TREATMENT APPROACHES AND OUTCOMES

EHA Library, Veit Bücklein, 4161223

PHASE 1/2 STUDY OF DONOR-DERIVED ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR T CELLS (VCAR33) FOR RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Guenther Koehne, 4161225

DIAGNOSIS, PREDICTORS AND OUTCOMES FOR IMMUNE EFFECTOR CELL ASSOCIATED ENTEROCOLITIS IN MULTIPLE MYELOMA PATIENTS RECEIVING CILTA-CEL

EHA Library, Kenneth Jin Chang Lim, 4161226

EMAPALUMAB IN PEDIATRIC PATIENTS WITH HIGH-GRADE CYTOKINE RELEASE SYNDROME (CRS) FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY

EHA Library, Jing Zhang, 4161227

HYPOXIA-RESPONSIVE CEA CAR-T CELLS THERAPY FOR RELAPSED STAGE IV NON-SMALL CELL LUNG CANCER: A SINGLE-ARM, OPEN-LABEL, PHASE I TRIAL

EHA Library, Shuang Wei, 4161228

CD19 CAR-T CELLS WITH ENHANCED TSCM IMMUNOPHENOTYPE PRODUCED BY PIGGYBAC TRANSPOSON SYSTEM FOR THE THERAPY OF REFRACTORY B-CELL MALIGNANCIES - PRELIMINARY RESULTS OF PHASE I CLINICAL TRIAL

EHA Library, Pavel Otáhal, 4161230

SINGLE-CELL IMMUNOPHENOTYPING OF CD19-CAR T CELLS IN PEDIATRIC BCP-ALL: INSIGHTS INTO CYTOKINE RELEASE SYNDROME AND TOCILIZUMAB-DRIVEN IMMUNE MODULATION.

EHA Library, Aleksandra Oszer, 4161231

LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA TREATED WITH PRIZLONCABTAGENE AUTOLEUCEL

EHA Library, Aibin Liang, 4161233

OPTIMIZED TRANSDUCTION OF MPB CD34+ CELLS INCREASE TRANSDUCTION EFFICIENCY AND VCN WHILE PRESERVING STEMNESS: TOWARDS A PHASE IIB CLINICAL TRIAL OF GENE THERAPY FOR TDT BETA-THALASSEMIA.

EHA Library, Samantha Scaramuzza, 4161234

INCIDENCE OF CARDIOTOXICITY IN OUTPATIENT CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES; A SINGLE CENTRE RETROSPECTIVE STUDY

EHA Library, Aminah Tayyab, 4161235

HIGH EFFICACY AND SAFETY OF A NOVEL ANTI-CD20 CAR-T CELL THERAPY, LY007 IN RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Lingshuang Sheng, 4161236

A MULTI-CENTER REAL-LIFE ANALYSIS ON PATIENTS WITH LARGE B-CELL LYMPHOMA AFTER FAILURE OF CAR-T CELLS THERAPY.

EHA Library, Mirko Farina, 4161237

CORRELATION OF NON-INVASIVE HEMOGLOBIN MEASUREMENT TO VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Kunjan Rana, 4161239

A COMPUTATIONAL ANALYSIS OF IMMUNE RECONSTITUTION DYNAMICS IN ADULTS WITH SICKLE CELL DISEASE UNDERGOING HLA-IDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Elisabeth Dovern, 4161241

REAL WORLD DATA ON PREVALENCE, CHARACTERISTICS AND OUTCOME OF MONOCLONAL GAMMOPATHIES IN ADULT SICKLE CELL DISEASE PATIENTS: A SINGLE CENTER EXPERIENCE.

EHA Library, Maria Dimopoulou, 4161243

MARKERS OF HEMOLYSIS AND CARDIAC FUNCTION IN SICKLE CELL DISEASE: A GENOTYPE-BASED ANALYSIS

EHA Library, Arman Sarshoghi, 4161245

INDIVIDUAL PATIENT ADHESIVE PHENOTYPES DEFINED BY FLOW ADHESION OF WHOLE BLOOD TO P-SELECTIN PREDICTS BIOLOGIC RESPONSE TO CRIZANLIZUMAB ADMINISTERED IN THE REAL WORLD CLINICAL SETTING

EHA Library, Jennell White, 4161246

SEROPREVALENCE OF SARS-COV-2 AND VACCINE EFFECTIVENESS IN INDIVIDUALS WITH SICKLE CELL DISEASE: COVIDODREP THE FRENCH MULTICENTER PROSPECTIVE STUDY.

EHA Library, Luu-Ly Pham, 4161247

POCIREDIR, A POTENT AND SELECTIVE EED INHIBITOR FOR THE TREATMENT OF SICKLE CELL DISEASE, INDUCES TARGET ENGAGEMENT AND GENE EXPRESSION CHANGES THAT ARE SPECIFIC AND REVERSIBLE IN WILD-TYPE MICE

EHA Library, Caterina Minniti, 4161249

IMPROVEMENT IN CEREBRAL OXYGEN SATURATIONS AND VASOREACTIVITY AFTER 12 MONTHS OF VOXELOTOR MEASURED BY NEAR-INFRARED SPECTROSCOPY (NIRS) IN SICKLE CELL DISEASE PATIENTS

EHA Library, Gonzalo De Luna, 4161250

PATIENT-REPORTED VASO-OCCLUSIVE EVENTS, THEIR ASSOCIATED PAIN SEVERITY, AND IMPACT OF SICKLE CELL DISEASE ON FATIGUE AND QUALITY OF LIFE: A REAL-WORLD SURVEY IN THE UNITED STATES

EHA Library, Oladipo Cole, 4161253

INVESTIGATING THE RELATIONSHIP BETWEEN HIGH-SENSITIVITY TROPONIN, CLINICAL OUTCOMES AND HEMOLYTIC MARKERS IN ADULTS WITH SICKLE CELL DISEASE.

EHA Library, Najibah Galadanci, 4161254

UPDATED SAFETY AND EFFICACY RESULTS OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TREATING TRANSFUSION-DEPENDENT ß-THALASSEMIA

EHA Library, Hui Xu, 4161255

14-3-3Ζ COORDINATES CROSSTALK BETWEEN TRANSFERRIN RECEPTOR-1 AND ERYTHROPOIETIN RECEPTOR SIGNALING TO REGULATE ERYTHROID DIFFERENTIATION AND APOPTOSIS

EHA Library, Gorawin Chaiyakitpattana, 4161256

OVERALL SURVIVAL AND MORBIDITY AMONG ADULTS WITH THALASSEMIA IN ENGLAND: A RETROSPECTIVE ANALYSIS USING ROUTINELY COLLECTED HEALTHCARE DATA FROM 2008 TO 2020

EHA Library, Khaled M. Musallam, 4161257

PARTIAL REPLACEMENT OF POST-TRANSPLANT CYCLOPHOSPHAMIDE WITH BENDAMUSTINE AS GVHD PROPHYLAXIS IN HAPLOIDENTICAL STEM CELL TRANSPLANTS IN PEDIATRIC PATIENTS:EXPERIENCE FROM A TERTIARY CARE CENTER

EHA Library, Ranjith CS, 4161166

CAUSES AND CONSEQUENCES OF CLONAL HEMATOPOIESIS WITH UNKNOWN DRIVERS IN 409,553 WHOLE-GENOME SEQUENCED UK BIOBANK PARTICIPANTS

EHA Library, Sean Wen, 4161169

LOSS OF HEPCIDIN IMPAIRS 5-FU-INDUCED HEMATOPOIETIC STEM CELL REGENERATION

EHA Library, Marta Lopes, 4161170

MAINTENANCE OF QUIESCENT HEMATOPOIETIC STEM CELLS ACROSS DEVELOPMENT IN SINGLE GROWTH FACTOR-BASED CULTURE

EHA Library, Margarita MacAldaz, 4161171

DEVELOPMENTAL DIFFERENCES IN HEMATOPOIETIC LINEAGE DIFFERENTIATION REVEALED BY SINGLE CELL ATAC-SEQ OF FIRST TRIMESTER HUMAN FETAL LIVER

EHA Library, Sara Palo, 4161175

EXPRESSION OF KIT D814V IN MURINE HEMATOPOIETIC STEM CELLS RESULTS IN AN ADVANCED SYSTEMIC MASTOCYTOSIS PHENOTYPE WITH ASSOCIATED MYELOID NEOPLASM

EHA Library, Simona Stivala, 4161176

MACROPHAGE DEPLETION ALTERS MSC FUNCTION AND DIFFERENTIATION UNDER CHRONIC STRESS CONDITIONS

EHA Library, Sanja Momčilović, 4161180

SINGLE-CELL MAPPING OF HUMAN BONE MARROW STROMAL CELLS REVEALS SUBPOPULATION DIVERSITY AND STRESS-INDUCED REMODELING

EHA Library, Charles Bataclan, 4161181

THE GENERATION OF A TRACEABLE DNMT3A AND TET2 KNOCKOUT IN HUMAN HSCS ENABLES IN VITRO AND IN VIVO MODELING OF CLONAL HEMATOPOIESIS.

EHA Library, Bauke de Boer, 4161182

CELL DIVISION IS ABSENT DURING LINEAGE COMMITMENT OF HEMATOPOIETIC PROGENITOR CELLS

EHA Library, Yongjian Yue, 4161183

EXPANDED TRANSCRIPTION FACTOR NETWORK AND EARLY MEGAKARYOPOIESIS REGULATION BY THE GFI1B-KDM1A-HDAC COMPLEX IN THE IMMORTALIZED MEGAKARYOCYTE PROGENITOR CELL LINE IMMKCL

EHA Library, Eshani Ganjoo, 4161186

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-INDUCED ADIPOGENIC BIAS OF BONE MARROW MESENCHYMAL STROMAL CELLS: EVIDENCE OF SKEWED FATE AND VARIABLE REPROGRAMMING

EHA Library, Bexultan Kazybay, 4161188

DISRUPTED GLUTAMINE METABOLISM ALTERS MACROPHAGE FUNCTION IN THE BONE MARROW.

EHA Library, Maddie Bristow, 4161191

INNOVATIVE SDAB-BASED CAR-T CELLS TARGETING BCMA OUTPERFORM CURRENT CAR-T THERAPIES FOR MULTIPLE MYELOMA

EHA Library, Juan Rodriguez-Madoz, 4161193

TARGETED LIPID NANOPARTICLE DELIVERY ENABLES IN VIVO HBG1/2 GENOME EDITING IN NON-HUMAN PRIMATES

EHA Library, Anshul Gupta, 4161194

TREATMENT WITH IMMUNOCHEMOTHERAPY DECREASES THE FITNESS OF CD19 CAR T-CELLS IN DLBCL

EHA Library, Tessa Knol, 4161195

ENHANCED LEUKEMIA IMMUNOTHERAPY WITH EXPANDED NKG2C+ NATURAL KILLER CELLS

EHA Library, Manja Wobus, 4161196

HIGHLY EFFICIENT AND SEAMLESS IN VIVO SELECTION OF LONG-RANGE GENE-EDITED HSPCS BY TARGETING HAPLOINSUFFICIENT GENES

EHA Library, Alessandra Weber, 4161197

INTEGRATED METABOLIC AND CYTOKINE PROFILING REVEALS IN VIVO METABOLIC CHECKPOINTS FOR CAR T-CELLS EFFICACY

EHA Library, Josquin Moraly, 4161198

CAR-T CELLS FROM PATIENTS WITH NON-HODGKIN LYMPHOMAS SECRETE FACTORS ABLE TO ACTIVATE THE MONOCYTIC-MACROPHAGIC TRANSITION: AN IN VITRO MODEL

EHA Library, Besjana Xhahysa, 4161201

ERYTHROID SPECIFIC EPIGENETIC SUPPRESSION OF BCL11A OR ZNF410 EFFICIENTLY REACTIVATES GAMMA GLOBIN EXPRESSION IN NORMAL AND THALASSEMIC CD34+ CELLS

EHA Library, Kiriaki Paschoudi, 4161203

IN-DEPTH MOLECULAR AND CELLULAR CHARACTERIZATION OF A SENESCENT-LIKE, TERMINALLY DIFFERENTIATED CD8+ T CELL SUBSET IDENTIFIES A NOVEL METABOLIC TARGET FOR CANCER IMMUNOTHERAPY

EHA Library, Lea Philine Märker, 4161204

CMV SEROPOSITIVITY INFLUENCES T CELL RECONSTITUTION FOLLOWING CAR-T THERAPY

EHA Library, Jared Darcy, 4161206

ENGINEERING IPSC-DERIVED UNIVERSAL CAR-T CELLS WITH DUAL CD19/BCMA SPECIFICITY FOR AUTOIMMUNE DISEASE THERAPY

EHA Library, Yongqin Li, 4161207

FEATURES OF MONOCYTE IMMUNOPHENOTYPE IN LEUKOCONCENTRATES OF PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Maria Morozova, 4161209

CAR-T CELL DYNAMICS AND MYELOID-CELL ALTERED PROFILE ARE ASSOCIATED WITH CLINICAL OUTCOME IN ANTI-CD19 CAR-T CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL MALIGNANCIES: A REAL-LIFE COHORT STUDY

EHA Library, Maddalena Noviello, 4161210

MAXIMIZING SAFETY AND EFFICACY IN HEMATOPOIETIC STEM CELLS GENE THERAPY

EHA Library, Valeriya Olevska, 4161214

ENHANCING CAR-T CELL HOMING TO AML BONE MARROW VIA CHEMOKINE RECEPTOR ENGINEERING

EHA Library, Alice Pievani, 4161215

EXPERIENCE OF USING A MICRONUCLEUS TEST TO CONTROL GENETIC INSTABILITY OF CAR-T LYMPHOCYTES AFTER TRANSDUCTION WITH LENTIVIRUS PARTICLES

EHA Library, Svetlana Popova, 4161216

AUC FLUDARABINE AND PRODUCT CHOICE ARE MAIN PREDICTORS OF CRS/ICANS AFTER CAR T CELL THERAPY: GENERATION OF AN IMPROVED MODEL

EHA Library, Keven Hoerster, 4161218

FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FASTCAR-T GC012F (AZD0120) FOR PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

EHA Library, Jingjing Feng, 4161220

4-YEAR UPDATE OF PHASE 2 ELARA TRIAL: CLINICAL OUTCOMES OF TISAGENLECLEUCEL IN PATIENTS (PTS) WITH HIGH-RISK RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

EHA Library, Catherine Thieblemont, 4161224

IMPACT OF PRE-LYMPHODEPLETION (PRE LD) AND DAY 30 (M1) IMMUNE CELL COUNTS ON OUTCOMES OF CAR T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Suheil Albert Atallah-Yunes, 4161229

PREGNANCY AND INFANT OUTCOMES POST-CD19-DIRECTED CAR-T THERAPY: TISAGENLECLEUCEL (TISA-CEL) AND/OR HUCAR19 (CTL119)

EHA Library, Marianne Ifversen, 4161232

COST-EFFECTIVENESS OF REGULAR RED BLOOD CELL EXCHANGE FOR PEDIATRIC SICKLE CELL DISEASE PATIENTS AT HIGH RISK OF STROKE: A HEALTH ECONOMIC ANALYSIS FROM THE FRENCH HEALTHCARE SYSTEM PERSPECTIVE

EHA Library, Ghofran Kamoun, 4161238

PRELIMINARY PHARMACODYNAMIC BIOMARKER RESULTS IN PATIENTS WITH SICKLE CELL DISEASE FOLLOWING TREATMENT WITH OSIVELOTOR IN A MULTICENTER PHASE 2/3 TRIAL

EHA Library, Mira Pochron, 4161240

ESTABLISHING CONSENSUS ON THE KEY COMPONENTS OF OPTIMAL TRANSITION FROM PAEDIATRIC TO ADULT CARE IN SICKLE CELL DISEASE ACROSS EUROPE

EHA Library, Mariangela Pellegrini, 4161242

EX VIVO ACTIVATION OF PYRUVATE KINASE BY TEBAPIVAT REDUCES SICKLING AND RED BLOOD CELL ADHESION IN SICKLE CELL DISEASE

EHA Library, Minke Rab, 4161244

MACHINE LEARNING-BASED DETECTION OF HEMOGLOBIN S AND HEMOGLOBIN C CARRIERS IN THE UK GENERAL POPULATION: A STUDY ON 469,248 GENOTYPED GENERAL POPULATION INDIVIDUALS FROM THE UK BIOBANK

EHA Library, Frederik Christensen, 4161248

MEEXCALC APP, A CALCULATOR FOR MANUAL ERITHROEXCHANGE IN SCD

EHA Library, Gian Luca Forni, 4161251

INNOVATIVE MODEL FOR CREATION AND USE OF CO-DEVELOPED PAIN MANAGEMENT PLANS FOR PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Abraham Haimed, 4161252

LUSPATERCEPT UNDER AN ' EARLY ACCESS PROGRAM': AN ITALIAN MULTICENTRE EXPERIENCE

EHA Library, Raffaella ORIGA, 4161258

CHARACTERIZING THE GENETIC ARCHITECTURE OF DRUG RESPONSE IN TRANSFUSION-DEPENDENT THALASSEMIA

EHA Library, Anthony Iscaro, 4161259

REAL WORLD DATA ON IMPROVING ANEMIA WITHOUT TRANSFUSIONS WITH LUSPATERCEPT IN ß-THALASSEMIC PATIENTS WITH COMORBIDITIES AND/OR ALLOIMMUNIZATION, WHO CONVERT TO TRANSFUSION-DEPENDENT LATE IN ADULT LIFE.

EHA Library, Maria Dimopoulou, 4161260

CHANGES IN TRANSFUSION BURDEN AND IRON OVERLOAD PARAMETERS IN TRANSFUSION-DEPENDENT ß-THALASSEMIA PATIENTS TREATED WITH LUSPATERCEPT: A REAL-LIFE STUDY

EHA Library, Yesim Aydinok, 4161261

IMPACT OF GENE THERAPY ON PHYSICAL GROWTH OF PEDIATRIC PATIENTS WITH ß-THALASSEMIA: A PROSPECTIVE COHORT STUDY

EHA Library, Jingyu Zhao, 4161262

LEFT VENTRICULAR DIASTOLIC AND SYSTOLIC FUNCTIONS BY CARDIAC MAGNETIC RESONANCE IN TRANSFUSION-DEPENDENT BETA THALASSEMIA: CLINICAL AND OUTCOME CORRELATES

EHA Library, Antonella Meloni, 4161263

SURVIVAL OF PATIENTS WITH CONGENITAL RED BLOOD CELL DISORDERS IN COMPARISON WITH AGE, SEX AND ORIGIN MATCHED POPULATIONS: A DANISH REGISTER-BASED ANALYSIS

EHA Library, Dana Lawrie, 4161264